1887

Abstract

The antimicrobial activity of cetylpyridinium chloride (CPC) and miramistin (MST) solutions at different concentrations (5×10 to 0.4 %) and a dressing, containing 0.15 % CPC, were tested against , and after 30 (solutions) and 60 min (fleece) incubation, respectively. Furthermore, the cytotoxic effects of CPC and MST were examined in human keratinocyte (HaCaT) and murine fibroblast (L929) cell lines. A dose of 3×10 % CPC or MST was sufficient to entirely eradicate after 30 min incubation. To achieve the same effect, higher concentrations were required against (0.025 % CPC; 0.0125 % MST) and (0.5 % CPC; 0.05 % MST). The CPC-fleece showed a high antiseptic effect against all three bacterial strains, although it did not completely eliminate . Both substances showed a high cytotoxic impact at higher tested concentrations (CPC >3×10 %; MST >8×10 %). CPC showed high antimicrobial potency at low concentrations against , accompanied by low cytotoxic (side) effects at these concentrations, whilst the required minimal concentration to eradicate and was shown to be cytotoxic for keratinocytes and fibroblasts. The necessary antibacterial amounts of MST were lower, but also cytotoxic in direct contact with typical human wound cells. With regard to demographic changes and increasing bacterial resistance, new effective antiseptics, such as CPC and MST, incorporated in wound dressings without releasing an active substance could help to improve the treatment and healing rates of chronic wounds.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000034
2015-04-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/4/407.html?itemId=/content/journal/jmm/10.1099/jmm.0.000034&mimeType=html&fmt=ahah

References

  1. Agafonov A. P., Ignat’ev G. M., Svistov V. V., Smirnov I. V., Krivoshein IuS.. ( 2005;a). [ In vitro study of antiviral activity of myramistin against measles and mumps viruses. ]. Antibiot Khimioter 50:, 17–19 (in Russian).[PubMed]
    [Google Scholar]
  2. Agafonov A. P., Skarnovich M. O., Petrishchenko V. A., Shishkina L. N., Sergeev A. N., Svistov V. V., Smirnov I. V., Kirichenko N. A., Krivoshein IuS.. ( 2005;b). [ In vitro study of antiviral activity of myramistin against subtypes H3N2 and H5N1 of influenza virus. ]. Antibiot Khimioter 50:, 9–11 (in Russian).[PubMed]
    [Google Scholar]
  3. Arzumanian V. G.. ( 2002;). [Minimum inhibitory concentrations of various antifungal agents against basidiomycetes clinical isolates]. . Antibiot Khimioter 47:, 7–10 (in Russian).[PubMed]
    [Google Scholar]
  4. Beele H., Meuleneire F., Nahuys M., Percival S. L.. ( 2010;). A prospective randomised open label study to evaluate the potential of a new silver alginate/carboxymethylcellulose antimicrobial wound dressing to promote wound healing. . Int Wound J 7:, 262–270. [CrossRef][PubMed]
    [Google Scholar]
  5. Costa X., Laguna E., Herrera D., Serrano J., Alonso B., Sanz M.. ( 2013;). Efficacy of a new mouth rinse formulation based on 0.07 % cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial. . J Clin Periodontol 40:, 1007–1015. [CrossRef][PubMed]
    [Google Scholar]
  6. Daeschlein G.. ( 2013;). Antimicrobial and antiseptic strategies in wound management. . Int Wound J 10: (Suppl. 1), 9–14. [CrossRef][PubMed]
    [Google Scholar]
  7. Demidova-Rice T. N., Hamblin M. R., Herman I. M.. ( 2012;). Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. . Adv Skin Wound Care 25:, 304–314. [CrossRef][PubMed]
    [Google Scholar]
  8. Deutsches Institut für Normung ( 2005;a). DIN EN 1040: Chemical Disinfectants and Antiseptics – Quantitative Suspension Test for the Evaluation of Basic Bactericidal Activity of Chemical Disinfectants and Antiseptics – Test Method and Requirements (Phase 1). Berlin:: Beuth;.
    [Google Scholar]
  9. Deutsches Institut für Normung ( 2005;b). DIN EN 1275: Chemical Disinfectants and Antiseptics – Quantitative Suspension Test for the Evaluation of Basic Fungicidal or Basic Yeasticidal Activity of Chemical Disinfectants and Antiseptics – Test Method and Requirements (Phase 1). Berlin:: Beuth;.
    [Google Scholar]
  10. Dumville J. C., Deshpande S., O’Meara S., Speak K.. ( 2013;). Foam dressings for healing diabetic foot ulcers. . Cochrane Database Syst Rev 6:, CD009111.[PubMed]
    [Google Scholar]
  11. Eberlein T., Assadian O.. ( 2010;). Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination. . Skin Pharmacol Physiol 23: (Suppl.), 45–51. [CrossRef][PubMed]
    [Google Scholar]
  12. Eberlein T., Haemmerle G., Signer M., Gruber Moesenbacher U., Traber J., Mittlboeck M., Abel M., Strohal R.. ( 2012;). Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. . J Wound Care 21:, 12–20. [CrossRef][PubMed]
    [Google Scholar]
  13. Fu J., Wei P., Zhao C., He C., Yan Z., Hua H.. ( 2014;). In vitro antifungal effect and inhibitory activity on biofilm formation of seven commercial mouthwashes. . Oral Dis 20:, 815–820.[PubMed]
    [Google Scholar]
  14. Gallant-Behm C. L., Yin H. Q., Liu S., Heggers J. P., Langford R. E., Olson M. E., Hart D. A., Burrell R. E.. ( 2005;). Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. . Wound Repair Regen 13:, 412–421. [CrossRef][PubMed]
    [Google Scholar]
  15. Gottrup F., Apelqvist J., Bjarnsholt T., Cooper R., Moore Z., Peters E. J. G., Probst S.. ( 2013;). EWMA document: antimicrobials and non-healing wounds. Evidence, controversies and suggestions. . J Wound Care 22: (Suppl.), S1–S89. [CrossRef][PubMed]
    [Google Scholar]
  16. Gutiérrez-Martín C. B., Yubero S., Martínez S., Frandoloso R., Rodríguez-Ferri E. F.. ( 2011;). Evaluation of efficacy of several disinfectants against Campylobacter jejuni strains by a suspension test. . Res Vet Sci 91:, e44–e47. [CrossRef][PubMed]
    [Google Scholar]
  17. Habets M. G., Brockhurst M. A.. ( 2012;). Therapeutic antimicrobial peptides may compromise natural immunity. . Biol Lett 8:, 416–418. [CrossRef][PubMed]
    [Google Scholar]
  18. Heyer K., Augustin M., Protz K., Herberger K., Spehr C., Rustenbach S. J.. ( 2013;). Effectiveness of advanced versus conventional wound dressings on healing of chronic wounds: systematic review and meta-analysis. . Dermatology 226:, 172–184. [CrossRef][PubMed]
    [Google Scholar]
  19. Hooper S. J., Williams D. W., Thomas D. W., Hill K. E., Percival S. L.. ( 2012;). An in vitro comparison of two silver-containing antimicrobial wound dressings. . Ostomy Wound Manage 58:, 16–22.[PubMed]
    [Google Scholar]
  20. International Organization for Standardization (2012). Textiles – Determination of Antibacterial Activity of Textile Products (ISO/DIS 20743:2012). http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=59586..
  21. Koburger T., Hübner N. O., Braun M., Siebert J., Kramer A.. ( 2010;). Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. . J Antimicrob Chemother 65:, 1712–1719. [CrossRef][PubMed]
    [Google Scholar]
  22. Lamb H. M., Wiseman L. R.. ( 1998;). Pexiganan acetate. . Drugs 56:, 1047–1052. [CrossRef][PubMed]
    [Google Scholar]
  23. Lio P. A., Kaye E. T.. ( 2004;). Topical antibacterial agents. . Infect Dis Clin North Am 18:, 717–733, x. [CrossRef][PubMed]
    [Google Scholar]
  24. Lipsky B. A., Holroyd K. J., Zasloff M.. ( 2008;). Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. . Clin Infect Dis 47:, 1537–1545. [CrossRef][PubMed]
    [Google Scholar]
  25. O’Meara S., Martyn-St James M.. ( 2013;). Foam dressings for venous leg ulcers. . Cochrane Database Syst Rev 5:, CD009907.[PubMed]
    [Google Scholar]
  26. Sen C. K., Gordillo G. M., Roy S., Kirsner R., Lambert L., Hunt T. K., Gottrup F., Gurtner G. C., Longaker M. T.. ( 2009;). Human skin wounds: a major and snowballing threat to public health and the economy. . Wound Repair Regen 17:, 763–771. [CrossRef][PubMed]
    [Google Scholar]
  27. Sreenivasan P. K., Haraszthy V. I., Zambon J. J.. ( 2013;). Antimicrobial efficacy of 0.05 % cetylpyridinium chloride mouthrinses. . Lett Appl Microbiol 56:, 14–20. [CrossRef][PubMed]
    [Google Scholar]
  28. Storm-Versloot M. N., Vos C. G., Ubbink D. T., Vermeulen H., Westerbos S. J.. ( 2010;). Topical silver for preventing wound infection. . Cochrane Database Syst Rev 3:, CD006478.[PubMed]
    [Google Scholar]
  29. Sütterlin S., Tano E., Bergsten A., Tallberg A.-B., Melhus A.. ( 2012;). Effects of silver-based wound dressings on the bacterial flora in chronic leg ulcers and its susceptibility in vitro to silver. . Acta Derm Venereol 92:, 34–39. [CrossRef][PubMed]
    [Google Scholar]
  30. Thomas S., McCubbin P.. ( 2003;). A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. . J Wound Care 12:, 101–107. [CrossRef][PubMed]
    [Google Scholar]
  31. Vasil’eva T. V., Raskidailo A. S., Arutcheva A. A., Okropiridze G. G., Petrakov A. A., Urazgil’deev Z. I., Kovalenko T. M.. ( 1993;). [ Antibacterial activity and clinical effectiveness of the new antiseptic miramistin. ]. Antibiot Khimioter 38:, 61–63 (in Russian).[PubMed]
    [Google Scholar]
  32. Watanabe E., Tanomaru J. M., Nascimento A. P., Matoba-Júnior F., Tanomaru-Filho M., Yoko Ito I.. ( 2008;). Determination of the maximum inhibitory dilution of cetylpyridinium chloride-based mouthwashes against Staphylococcus aureus: an in vitro study. . J Appl Oral Sci 16:, 275–279. [CrossRef][PubMed]
    [Google Scholar]
  33. Wiegand C., Heinze T., Hipler U.-C.. ( 2009;). Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. . Wound Repair Regen 17:, 511–521. [CrossRef][PubMed]
    [Google Scholar]
  34. Wright J. B., Lam K., Hansen D., Burrell R. E.. ( 1999;). Efficacy of topical silver against fungal burn wound pathogens. . Am J Infect Control 27:, 344–350. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000034
Loading
/content/journal/jmm/10.1099/jmm.0.000034
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error